SOLOGRIP III HANDPIECE
Report
- Report Number
- 2950727-2014-00019
- Event Type
- Injury
- Date Received
- September 15, 2014
- Date of Event
- July 1, 2014
- Report Date
- August 18, 2014
- Manufacturer
- CARDIOGENESIS CORPORATION
- Product Code
- MNO
- PMA / PMN Number
- P970029
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- PHYSICIAN
Narratives
ACCORDING TO THE CASE REPORT FORM REPORT RECEIVED FROM THE ANGINA RELIEF REGISTRY, THE PATIENT UNDERWENT A CABG+TMR PROCEDURE ON (B)(6) 2014 WITH A TOTAL OF 18 CHANNELS PLACED. ON (B)(6) 2014 THE PATIENT NOTICED THE INCISION TO BE OPEN AND BLEEDING WITH A FOUL SMELL. A REVIEW OF MANUFACTURING AND INSPECTION RECORDS FROM THE LOT OF THIS DEVICE WAS PERFORMED AND ALL COMPONENTS WERE FOUND TO MEET SPECIFICATION. THIS COMPLAINT SUGGESTS THAT WHILE THE PATIENT PRESENTED WITH A POSSIBLE ADVERSE EVENT FOLLOWING THE PROCEDURE, IT DOES NOT APPEAR TO BE RELATED TO THE HANDPIECE. THE INSTRUCTIONS FOR USE (IFU) WARN, "INSPECT SEALED, STERILE PACKAGE BEFORE OPENING. PRODUCT IS STERILE ONLY IN UNOPENED, UNDAMAGED PACKAGE. IF PACKAGE IS OPENED OR DAMAGED, OR IF SEAL IS BROKEN, CONTENTS MAY NOT BE STERILE AND MAY CAUSE INFECTION IN THE PATIENT." ACCORDING TO DOCUMENTATION, ALL AVAILABLE RECORDS SHOW THE HANDPIECES WERE CORRECTLY ASSEMBLED FROM APPROVED COMPONENTS AND WERE INSPECTED TO SPECIFICATIONS. THERE IS NO INDICATION THAT AN ERROR OR DEFICIENCY OCCURRED AT CRYOLIFE. THE INSTRUCTIONS FOR USE PROVIDE ADEQUATE WARNINGS AND PRECAUTIONS. .
THIS INVESTIGATION IS CURRENTLY ONGOING. ANY ADDITIONAL INFORMATION WILL BE PROVIDED IN THE FOLLOW-UP REPORT.
FOLLOW UP 1 WAS FOR A COMPLAINT UNRELATED TO COMPLAINT (B)(4). THIS MEDWATCH CONTAINS THE CORRECT INFORMATION FOR COMPLAINT (B)(4). ACCORDING TO THE CASE REPORT FORM, THE PATIENT WAS RE-HOSPITALIZED FOR A MINOR SUPERFICIAL STERNAL INFECTION TREATED SUCCESSFULLY WITH ANTIBIOTICS AND LOCAL WOUND CARE. THE TMR PROCEDURE TOOK PLACE ON (B)(6) 2014, AND THE PATIENT WAS RE-HOSPITALIZED 20 DAYS LATER ON (B)(6) 2014 FOR THE STERNAL INFECTION. A REVIEW OF MANUFACTURING AND INSPECTION RECORDS FROM THE LOT OF THIS DEVICE WAS PERFORMED AND ALL COMPONENTS WERE FOUND TO MEET SPECIFICATION. THIS COMPLAINT SUGGESTS THAT WHILE THE PATIENT PRESENTED WITH A POSSIBLE ADVERSE EVENT FOLLOWING THE PROCEDURE, IT DOES NOT APPEAR TO BE RELATED TO THE HANDPIECE. THE INSTRUCTIONS FOR USE (IFU) WARN, "INSPECT SEALED, STERILE PACKAGE BEFORE OPENING. PRODUCT IS STERILE ONLY IN UNOPENED, UNDAMAGED PACKAGE. IF PACKAGE IS OPENED OR DAMAGED, OR IF SEAL IS BROKEN, CONTENTS MAY NOT BE STERILE AND MAY CAUSE INFECTION IN THE PATIENT." ACCORDING TO DOCUMENTATION, ALL AVAILABLE RECORDS SHOW THE HANDPIECES WERE CORRECTLY ASSEMBLED FROM APPROVED COMPONENTS AND WERE INSPECTED TO SPECIFICATIONS. THERE IS NO INDICATION THAT AN ERROR OR DEFICIENCY OCCURRED AT CRYOLIFE. THE INSTRUCTIONS FOR USE PROVIDE ADEQUATE WARNINGS AND PRECAUTIONS.
ACCORDING TO THE CASE REPORT FORM, THE PATIENT WAS RE-HOSPITALIZED FOR A MINOR SUPERFICIAL STERNAL INFECTION TREATED SUCCESSFULLY WITH ANTIBIOTICS AND LOCAL WOUND CARE. THE TMR PROCEDURE TOOK PLACE ON (B)(6) 2014, AND THE PATIENT WAS RE-HOSPITALIZED 20 DAYS LATER ON (B)(6) 2014 FOR THE STERNAL INFECTION.
ACCORDING TO THE CASE REPORT FORM, THE PATIENT WAS RE-HOSPITALIZED FOR A MINOR SUPERFICIAL STERNAL INFECTION TREATED SUCCESSFULLY WITH ANTIBIOTICS AND LOCAL WOUND CARE. THE TMR PROCEDURE TOOK PLACE ON (B)(6) 2014, AND THE PATIENT WAS RE-HOSPITALIZED 20 DAYS LATER ON (B)(6) 2014 FOR THE STERNAL INFECTION.
THE PATIENT HAD A TMR PROCEDURE ON (B)(6) 2014. ON (B)(6) 2014 THE PATIENT NOTED INCISION OPEN AND BLEEDING WITH A FOUL SMELL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 568485 | SOLOGRIP III HANDPIECE | TRANSMYOCARDIAL REVASCULARISZATION LASER HANDPIECE | MNO | CARDIOGENESIS CORPORATION | HP-SG3 | TA-04032-10 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 59 YR | Other |